A Look At West Pharmaceutical Services (WST) Valuation After Strong Recent Share Price Momentum

West Pharmaceutical Services (WST) has seen significant short-term share price momentum, gaining nearly 24% over the last month, yet its longer-term performance is mixed. Analysts suggest a fair value of $338.57, indicating it is currently 9.6% undervalued, based on expected improvements in margins from new manufacturing lines and an expansion into higher-margin contract manufacturing. However, the stock appears expensive when compared to industry P/E ratios, suggesting market sentiment is split between potential upside and rich pricing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin